Pinned post
I joined PBS @NewsHour and @WmBrangham to discuss GLP-1 therapies and cancer risk - who might benefit, and who might not.
These are promising/powerful tools that could reduce the burden of obesity-related cancers.
@ASCO @WinshipAtEmory @BCRFcure
These are promising/powerful tools that could reduce the burden of obesity-related cancers.
@ASCO @WinshipAtEmory @BCRFcure
6:46